Issue 83, 2016

Simultaneous inhibition of EGFR and MET receptors with phytochemical conjugated magnetic nanocarriers: in silico and in vitro study

Abstract

Cross talk between Epidermal Growth Factor Receptor (EGFR) and hepatocyte growth factor or MET receptor has turned out to be a major challenge in cancer treatment. Inhibitors targeting both receptors, when expressed at elevated levels, can significantly reduce cancer cell progression. In the present work, methanolic extract (of Mentha piperita) coated super-paramagnetic iron oxide nanoparticles (SPIONs) were prepared and tested for effective inhibition of EGFR and MET receptors. Extract encapsulated SPIONs (20 ± 5 nm) showed high stability (zeta potential −62.9 mV), antioxidant activity (96% at 1 mg ml−1) and non-haemolytic activity (upto 2.5 mg ml−1). Dose dependent inhibition of EGF and MET receptors by encapsulated SPIONs (IC50 = 67 μg ml−1) was three-fold higher when compared to Mentha piperita extract. Molecular docking analysis with identified bioactive compounds revealed lowest binding energies for 1,3,8-P-menthatriene (−7.89 and −6.59 kcal mol−1), DL-alpha-tocopherol (−7.32 and −5.98 kcal mol−1) and β-sitosterol (−9.22 and −6.27 kcal mol−1) towards EGFR and MET receptors, respectively. Hydrophobic interactions were found to be crucial for the best docked ligands' (β-sitosterol, 1,3,8-P-menthatriene and DL-alpha-tocopherol) mediated EGFR/MET inhibition, irrespective of their hydrogen bonding.

Graphical abstract: Simultaneous inhibition of EGFR and MET receptors with phytochemical conjugated magnetic nanocarriers: in silico and in vitro study

Supplementary files

Article information

Article type
Paper
Submitted
06 May 2016
Accepted
17 Aug 2016
First published
18 Aug 2016

RSC Adv., 2016,6, 80121-80132

Simultaneous inhibition of EGFR and MET receptors with phytochemical conjugated magnetic nanocarriers: in silico and in vitro study

S. S. Ilangovan and S. Sen, RSC Adv., 2016, 6, 80121 DOI: 10.1039/C6RA11821F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements